Reported Consolidated quarterly numbers for Panacea Biotec are:Net Sales at Rs 140.73 crore in March 2022 down 16.37% from Rs. 168.27 crore in March 2021.
Quarterly Net Profit at Rs. 1,237.47 crore in March 2022 up 2385.69% from Rs. 54.14 crore in March 2021.
EBITDA stands negative at Rs. 26.14 crore in March 2022 down 547.6% from Rs. 5.84 crore in March 2021.
Panacea Biotec EPS has increased to Rs. 202.03 in March 2022 from Rs. 8.84 in March 2021.
Panacea Biotec shares closed at 144.05 on May 17, 2022 (NSE)
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'22 | Dec'21 | Mar'21 | | Net Sales/Income from operations | 140.73 | 155.88 | 168.27 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 140.73 | 155.88 | 168.27 | | EXPENDITURE | | Consumption of Raw Materials | 52.33 | 43.05 | 31.31 | | Purchase of Traded Goods | 4.92 | 7.72 | 3.70 | | Increase/Decrease in Stocks | 11.85 | -4.18 | 23.87 | | Power & Fuel | -- | -- | -- | | Employees Cost | 47.13 | 45.67 | 44.38 | | Depreciation | 11.15 | 10.55 | 11.58 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 54.69 | 51.76 | 64.07 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -41.34 | 1.31 | -10.64 | | Other Income | 4.05 | 1.66 | 4.90 | | P/L Before Int., Excpt. Items & Tax | -37.29 | 2.97 | -5.74 | | Interest | 30.66 | 52.13 | 46.91 | | P/L Before Exceptional Items & Tax | -67.95 | -49.16 | -52.65 | | Exceptional Items | 1,676.21 | -- | -- | | P/L Before Tax | 1,608.26 | -49.16 | -52.65 | | Tax | 370.79 | 0.04 | 1.49 | | P/L After Tax from Ordinary Activities | 1,237.47 | -49.20 | -54.14 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1,237.47 | -49.20 | -54.14 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 1,237.47 | -49.20 | -54.14 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 202.03 | -8.03 | -8.84 | | Diluted EPS | 202.03 | -8.03 | -8.84 | | EPS After Extra Ordinary | | Basic EPS | 202.03 | -8.03 | -8.84 | | Diluted EPS | 202.03 | -8.03 | -8.84 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes